Semba Biosciences specializes in advanced technologies for the development of innovative solutions in the field of bioprocessing. Their primary focus is on their proprietary MCC (Multi-Column Chromatography) technology, which enhances the efficiency and effectiveness of purification processes in biomanufacturing. This technology allows for the simultaneous processing of multiple samples, significantly reducing the time and resources required for purification while maintaining high product quality. Semba's MCC solutions are designed to streamline workflows and improve scalability, making them particularly valuable for companies involved in the production of biologics and other complex molecules.

In addition to their MCC technology, Semba Biosciences emphasizes the importance of scientific rigor and innovation in their approach to bioprocessing. They leverage a deep understanding of the underlying science to develop products that address the specific needs of their clients. By integrating cutting-edge research with practical applications, Semba aims to provide solutions that not only meet current industry demands but also anticipate future challenges in biomanufacturing. Their commitment to advancing bioprocessing technologies positions them as a key player in the biotechnology sector.

United States

Semba provides instruments, reagents and methods for efficient and scalable purification of biomolecules and chemicals to the worldwide research community.

Semba Biosciences

Company Details